FitzPatrick Margaret M
SEC CIK 1873879 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Dir | 10.7K | $21.8K | — | 2 | 2025-05-28 | 2026-09-01 |
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 18:43 | 2026-09-01 | ANTX | AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Dir | P - Purchase | $5.53 | +2,098 | 10.7K | +24% | +$11.6K | |
| 2025-05-29 | 2025-05-28 | ANTX | AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Dir | P - Purchase | $1.18 | +8,610 | 8,610 | New | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations